Semi-Annual Statement Of Income And Retained Earnings

Daito Pharmaceutical Co., Ltd. - Filing #7289262

Concept 2024-06-01 to
2024-11-30
2023-06-01 to
2023-11-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
1,471,000,000 JPY
2,289,000,000 JPY
Non-operating income
Non-operating income
73,000,000 JPY
72,000,000 JPY
Non-operating expenses
Non-operating expenses
73,000,000 JPY
46,000,000 JPY
Ordinary profit (loss)
1,470,000,000 JPY
2,314,000,000 JPY
Extraordinary income
Extraordinary income
409,000,000 JPY
0 JPY
Profit (loss) before income taxes
1,879,000,000 JPY
2,315,000,000 JPY
Income taxes - current
839,000,000 JPY
798,000,000 JPY
Income taxes - deferred
-66,000,000 JPY
22,000,000 JPY
Profit (loss)
718,000,000 JPY
1,494,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.